CartiPRO
Asset
Intra-articular atelocollagen injection providing structural matrix supplementation for cartilage repair and pain relief.
- Stage
- Human trials
- Modality
- Protein or enzyme
- Target
- Not known
- 5
- Indications
- 1
- Trial
- 1
- Developer
Indications
5Cartilage defects of the knee
Human trials, Active not recruiting, NCT07267793, clinicaltrials.gov, 7 Oct 2026
Degenerative joint disease of knee
Human trials, Active not recruiting, NCT07267793, clinicaltrials.gov, 7 Oct 2026
Knee osteoarthritis
Human trials, Active not recruiting, NCT07267793, clinicaltrials.gov, 7 Oct 2026
2 more
In the full profile
- Owner and partners1
- Trials1
- Competitors1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.